Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About ArcelorMittal (ADR) (MT)

Page 1 of 2

ArcelorMittal (ADR) (NYSE:MT) was in 7 hedge funds’ portfolio at the end of December. MT investors should be aware of an increase in hedge fund sentiment of late. There were 6 hedge funds in our database with MT positions at the end of the previous quarter.

ArcelorMittal (ADR) (NYSE:MT)

In today’s marketplace, there are tons of gauges shareholders can use to analyze Mr. Market. A duo of the most useful are hedge fund and insider trading activity. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the top fund managers can trounce the market by a very impressive margin (see just how much).

Just as beneficial, bullish insider trading sentiment is another way to break down the stock market universe. Just as you’d expect, there are plenty of stimuli for an executive to sell shares of his or her company, but only one, very simple reason why they would buy. Plenty of academic studies have demonstrated the useful potential of this strategy if piggybackers know where to look (learn more here).

With these “truths” under our belt, it’s important to take a glance at the recent action regarding ArcelorMittal (ADR) (NYSE:MT).

Hedge fund activity in ArcelorMittal (ADR) (NYSE:MT)

At the end of the fourth quarter, a total of 7 of the hedge funds we track were long in this stock, a change of 17% from the third quarter. With hedgies’ positions undergoing their usual ebb and flow, there exists a select group of notable hedge fund managers who were boosting their holdings meaningfully.

According to our comprehensive database, John Burbank’s Passport Capital had the most valuable position in ArcelorMittal (ADR) (NYSE:MT), worth close to $23.1 million, comprising 0.9% of its total 13F portfolio. Sitting at the No. 2 spot is Ken Griffin of Citadel Investment Group, with a $9.2 million call position; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Some other peers that hold long positions include D. E. Shaw’s D E Shaw, and Israel Englander’s Millennium Management.

As aggregate interest increased, key money managers were breaking ground themselves. Passport Capital, managed by John Burbank, initiated the most valuable position in ArcelorMittal (ADR) (NYSE:MT). Passport Capital had 23.1 million invested in the company at the end of the quarter. Guru Ramakrishnan’s Meru Capital also made a $1.7 million investment in the stock during the quarter. The following funds were also among the new MT investors: Jason Adler’s AlphaBet Management and Steven Cohen’s SAC Capital Advisors.

What have insiders been doing with ArcelorMittal (ADR) (NYSE:MT)?

Insider buying is particularly usable when the primary stock in question has seen transactions within the past half-year. Over the latest 180-day time frame, ArcelorMittal (ADR) (NYSE:MT) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s go over hedge fund and insider activity in other stocks similar to ArcelorMittal (ADR) (NYSE:MT). These stocks are Companhia Siderurgica Nacional (ADR) (NYSE:SID), Gerdau SA (ADR) (NYSE:GGB), Nucor Corporation (NYSE:NUE), POSCO (ADR) (NYSE:PKX), and Tenaris S.A. (ADR) (NYSE:TS). This group of stocks belong to the steel & iron industry and their market caps are similar to MT’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!